Use of Ultrasound for Measuring Size of Oral Tongue Cancers
Use of Transoral Ultrasound for Measuring Depth Of Invasion in Oral Tongue Carcinoma, and Comparing Obtained Measurements With Measurements From MRI With the Results Obtained From Pathological Examination of Surgically Resected Specimens
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to investigate the use intraoral ultrasound for measuring depth of invasion (DOI) in oral tongue squamous cell carcinoma. The DOI's measured on ultrasound and measurements from MRI scans, will be compared to the measurements made from pathological examination of removed specimens.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2020
CompletedFirst Submitted
Initial submission to the registry
October 28, 2020
CompletedFirst Posted
Study publicly available on registry
November 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedMarch 30, 2023
March 1, 2023
2 years
October 28, 2020
March 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation of DOI measured on ultrasound and on MRI compared to pathological examination
Measurement of DOI in millimeters
when pathological examination is made, within 4 weeks of US and MRi
Study Arms (1)
Ultrasound for measuring DOI in tongue tumors
EXPERIMENTALAll patients included with tongue carcinoma
Interventions
A transoral ultrasound scan of tongue tumors will be performed to assess the depth of invasion of the tumor
Eligibility Criteria
You may qualify if:
- Patients with squamous cell carcinoma on the lateral tongue
You may not qualify if:
- Patients with tumor elsewhere in the oral cavity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rigshospitalet Copenhagen University Hospital
Copenhagen, 2100, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mikkel Kaltoft, MD
Consultant
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant
Study Record Dates
First Submitted
October 28, 2020
First Posted
November 4, 2020
Study Start
October 15, 2020
Primary Completion
November 1, 2022
Study Completion
November 1, 2022
Last Updated
March 30, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share